1. Home
  2. EVOK vs IPDN Comparison

EVOK vs IPDN Comparison

Compare EVOK & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • IPDN
  • Stock Information
  • Founded
  • EVOK 2007
  • IPDN 2003
  • Country
  • EVOK United States
  • IPDN United States
  • Employees
  • EVOK N/A
  • IPDN N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • IPDN EDP Services
  • Sector
  • EVOK Health Care
  • IPDN Technology
  • Exchange
  • EVOK Nasdaq
  • IPDN Nasdaq
  • Market Cap
  • EVOK 4.2M
  • IPDN 4.3M
  • IPO Year
  • EVOK 2013
  • IPDN 2013
  • Fundamental
  • Price
  • EVOK $2.45
  • IPDN $1.97
  • Analyst Decision
  • EVOK
  • IPDN
  • Analyst Count
  • EVOK 0
  • IPDN 0
  • Target Price
  • EVOK N/A
  • IPDN N/A
  • AVG Volume (30 Days)
  • EVOK 27.3K
  • IPDN 36.7K
  • Earning Date
  • EVOK 03-13-2025
  • IPDN 05-14-2025
  • Dividend Yield
  • EVOK N/A
  • IPDN N/A
  • EPS Growth
  • EVOK N/A
  • IPDN N/A
  • EPS
  • EVOK N/A
  • IPDN N/A
  • Revenue
  • EVOK $10,249,415.00
  • IPDN $6,730,605.00
  • Revenue This Year
  • EVOK $99.03
  • IPDN N/A
  • Revenue Next Year
  • EVOK $60.15
  • IPDN N/A
  • P/E Ratio
  • EVOK N/A
  • IPDN N/A
  • Revenue Growth
  • EVOK 97.84
  • IPDN N/A
  • 52 Week Low
  • EVOK $2.40
  • IPDN $1.80
  • 52 Week High
  • EVOK $12.32
  • IPDN $18.90
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 26.36
  • IPDN 40.12
  • Support Level
  • EVOK $2.51
  • IPDN $2.40
  • Resistance Level
  • EVOK $2.81
  • IPDN $2.59
  • Average True Range (ATR)
  • EVOK 0.29
  • IPDN 0.21
  • MACD
  • EVOK -0.02
  • IPDN 0.05
  • Stochastic Oscillator
  • EVOK 8.12
  • IPDN 23.33

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.

Share on Social Networks: